enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Sucralfate - Wikipedia

   en.wikipedia.org/wiki/Sucralfate

   Sucralfate, sold under various brand names, is a medication used to treat stomach ulcers, gastroesophageal reflux disease (GERD), radiation proctitis, and stomach inflammation and to prevent stress ulcers. [3] [4] [5] Its usefulness in people infected by H. pylori is limited. [3]

3. Nizatidine - Wikipedia

   en.wikipedia.org/wiki/Nizatidine

   Nizatidine is a histamine H 2 receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. [2] It was patented in 1980 and approved for medical use in 1988. [3] [4] It was developed by Eli Lilly.

4. Gastroesophageal reflux disease - Wikipedia

   en.wikipedia.org/wiki/Gastroesophageal_reflux...

   Gastroesophageal reflux disease (GERD) or gastro-oesophageal reflux disease (GORD) is a chronic upper gastrointestinal disease in which stomach content persistently and regularly flows up into the esophagus, resulting in symptoms and/or complications.

5. Drugs for acid-related disorders - Wikipedia

   en.wikipedia.org/wiki/Drugs_for_acid-related...

   These drugs are among the most widely sold drugs in the world, and are generally considered effective. [3] When these medications are used long term, the lowest effective dose should be taken. [4] They may also be taken only when symptoms occur in those with frequent problems. [5] Proton-pump inhibitors are named using the suffix "-prazole".

6. FDA Approves New GERD Treatment Vonoprazan for ... - AOL

   www.aol.com/fda-approves-gerd-treatment...

   The FDA approved vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal reflux disease (GERD) in adults. GERD is a condition in which acidic stomach ...

7. Helicobacter pylori eradication protocols - Wikipedia

   en.wikipedia.org/wiki/Helicobacter_pylori...

   In areas of low clarithromycin resistance, including the United States, a 14-day course of "triple therapy" with an oral proton pump inhibitor, clarithromycin 500 mg, and amoxicillin 1 g (or, if penicillin allergic, metronidazole 500 mg), all given twice daily for 14 days, is recommended for first-line therapy. This regimen can achieve rates of ...